AMG
52
2
COST
63
5
EMN
56
7
GIS
28
2
EXR
60
3
GM
68
3
DE
56
10
CMG
67
3
GPC
37
2
OMC
61
6
PDCO
38
3
STX
56
4
D
45
5
INTU
54
3
HSIC
51
-3
ILMN
37
5
JWN
42
2
KMX
64
6
FMC
33
2
SJM
21
2
AMG
52
2
COST
63
5
EMN
56
7
GIS
28
2
EXR
60
3
GM
68
3
DE
56
10
CMG
67
3
GPC
37
2
OMC
61
6
PDCO
38
3
STX
56
4
D
45
5
INTU
54
3
HSIC
51
-3
ILMN
37
5
JWN
42
2
KMX
64
6
FMC
33
2
SJM
21
2
Financhill
Back

Cue Biopharma Vs. Biomarin Pharmaceutical Industry Stock Comparison

Sell
16

CUE
Cue Biopharma

Last Price:
1.05
Seasonality Move:
13.31%
Buy
60

BMRN
Biomarin Pharmaceutical

Last Price:
64.25
Seasonality Move:
12.47%
Sell
16
Cue Biopharma (CUE) is a Sell

Is Cue Biopharma a Buy, Sell or Hold?

  • The current Cue Biopharma [CUE] share price is $1.03. The Score for CUE is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
  • CUE is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
60
Biomarin Pharmaceutical (BMRN) is a Buy

Is Biomarin Pharmaceutical a Buy, Sell or Hold?

  • The current Biomarin Pharmaceutical [BMRN] share price is $63.45. The Score for BMRN is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • BMRN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

CUE Stock Price Chart

What is Cue Biopharma's stock price today?

  • The Cue Biopharma share price today is $1.03
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CUE is experiencing selling pressure, which indicates risk of future bearish movement.

BMRN Stock Price Chart

What is Biomarin Pharmaceutical's stock price today?

  • The Biomarin Pharmaceutical share price today is $63.45
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing buying pressure, which is a positive indicator for future bullish movement.

CUE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.04 Sell
Relative Strength Index (14 RSI): 37.67 Sell
Chaikin Money Flow: -356755 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.28 - 1.76) Sell
Bollinger Bands (100): (0.57 - 1.35) Buy

BMRN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.1 Sell
Relative Strength Index (14 RSI): 33.54 Sell
Chaikin Money Flow: 933432 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (64.12 - 69.52) Sell
Bollinger Bands (100): (68.19 - 87.29) Sell

CUE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.28 Sell
20-day SMA: 1.51 Sell
50-day SMA: 1.17 Sell
200-day SMA: 1.38 Sell
8-day EMA: 1.24 Sell
20-day EMA: 1.37 Sell
50-day EMA: 1.25 Sell
200-day EMA: 1.45 Sell

BMRN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 63.96 Sell
20-day SMA: 65.96 Sell
50-day SMA: 68.96 Sell
200-day SMA: 81.18 Sell
8-day EMA: 63.79 Sell
20-day EMA: 65.7 Sell
50-day EMA: 69.97 Sell
200-day EMA: 79.54 Sell

Cue Biopharma Earnings Growth & CUE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.40 per share, and an increase next year of $0.19 per share.

Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.23 per share, and an increase next year of $0.83 per share.

Cue Biopharma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Biomarin Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):